cbdMD, Inc. reported earnings results for the second quarter and six months ended March 31, 2023. For the second quarter, the company reported sales was USD 6.58 million compared to USD 9.95 million a year ago. Revenue was USD 6.24 million compared to USD 9.63 million a year ago. Net loss was USD 1.34 million compared to USD 4.66 million a year ago. Basic loss per share from continuing operations was USD 1.74 compared to USD 4.32 a year ago. Diluted loss per share from continuing operations was USD 1.74 compared to USD 4.32 a year ago.
For the six months, sales was USD 12.83 million compared to USD 19.81 million a year ago. Revenue was USD 12.33 million compared to USD 18.95 million a year ago. Net loss was USD 5.29 million compared to USD 23.82 million a year ago. Basic loss per share from continuing operations was USD 5.43 compared to USD 19.67 a year ago. Diluted loss per share from continuing operations was USD 5.43 compared to USD 19.67 a year ago.